Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.39 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.39 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27810816 | 1.00 | ABCB1 (0.50) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL18675299 | 0.91 | ABCB1 (0.49) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL24733700 | 0.91 | ABCB1 (0.49) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL23879129 | 0.91 | ABCB1 (0.49) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL29973797 | 0.90 | ABCB1 (0.44) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL16095581 | 0.88 | FOLH1 (0.48) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL29401229 | 0.88 | FOLH1 (0.48) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL16095584 | 0.88 | FOLH1 (0.48) | ABCB1ITGB3ITGA2BL3MBTL1SYK | |
| SCHEMBL28813126 | 0.88 | ITGB3 (0.46) | ABCB1ITGB3ITGA2BALDH1A1CTSL | |
| SCHEMBL248887 | 0.88 | ITGB3 (0.46) | ABCB1ITGB3ITGA2BALDH1A1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350189-A | Method for preparing N-methyl-N-benzyloxycarbonyl-L-aspartic acid-4-tert-butyl ester | 上海农林职业技术学院 | 2025-01-24 | — | — | CN | claimed |
| US-20250197450-A1 | METHOD FOR PRODUCING N-ALKYL AMINO ACID AND PEPTIDE INCLUDING N-ALKYL AMINO ACID | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-19 | — | — | US | disclosed |
| CN-119350189-A | Method for preparing N-methyl-N-benzyloxycarbonyl-L-aspartic acid-4-tert-butyl ester | 上海农林职业技术学院 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350189-A | Method for preparing N-methyl-N-benzyloxycarbonyl-L-aspartic acid-4-tert-butyl ester | 上海农林职业技术学院 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350189-A | Method for preparing N-methyl-N-benzyloxycarbonyl-L-aspartic acid-4-tert-butyl ester | 上海农林职业技术学院 | 2025-01-24 | — | — | CN | disclosed |
| EP-4414374-A1 | METHOD FOR PRODUCING N-ALKYL AMINO ACID AND PEPTIDE INCLUDING N-ALKYL AMINO ACID | Chugai Seiyaku Kabushiki Kaisha (JP) | 2024-08-14 | — | — | EP | disclosed |
| WO-2023127869-A1 | METHOD FOR PRODUCING N-ALKYL AMINO ACID AND PEPTIDE INCLUDING N-ALKYL AMINO ACID | 中外製薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| US-20230056969-A1 | METHOD FOR SYNTHESIZING PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-02-23 | — | — | US | disclosed |
| US-20220411462-A1 | METHODS FOR PRODUCING CYCLIC COMPOUNDS COMPRISING N-SUBSTITUTED AMINO ACID RESIDUES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-12-29 | — | — | US | disclosed |
| EP-4083051-A1 | METHOD FOR SYNTHESIZING PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-11-02 | — | — | EP | disclosed |
| US-20130281360-A1 | BROAD SPECTRUM ANTIBIOTIC ARYLOMYCIN ANALOGS | THE SCIPPS RESEARCH INSTITUTE (US) | 2013-10-24 | — | — | US | disclosed |
| US-20130053348-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING (US) | 2013-02-28 | — | — | US | disclosed |
| US-20130053348-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING (US) | 2013-02-28 | — | — | US | disclosed |
| US-20120135964-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120135964-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING (US) | 2012-05-31 | — | — | US | disclosed |
| US-8088793-B2 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088793-B2 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| CN-101821279-A | Certain chemical entities, compositions, and methods | CYTOKINETICS INC | 2010-09-01 | — | — | CN | disclosed |
| US-20090275537-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090275537-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275537-A1 | Certain chemical entities, compositions, and methods | MYLK, MYH2, MYH10 | ABCB1 1608/4885ITGB3 538/4885ITGA2B 657/4885 |
| US-20250197450-A1 | METHOD FOR PRODUCING N-ALKYL AMINO ACID AND PEPTIDE INCLUDING N-ALKYL AMINO ACID | NPPA, MGMT, ANPEP | ABCB1 2990/4885ITGB3 4361/4885ITGA2B 4652/4885 |
| US-20120135964-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | MYLK, MYH2, MYH10 | ABCB1 1608/4885ITGB3 538/4885ITGA2B 657/4885 |
| US-20220411462-A1 | METHODS FOR PRODUCING CYCLIC COMPOUNDS COMPRISING N-SUBSTITUTED AMINO ACID RESIDUES | NGLY1, NPPA, VIP | ABCB1 3568/4885ITGB3 4867/4885ITGA2B 4885/4885 |
| US-20230056969-A1 | METHOD FOR SYNTHESIZING PEPTIDE COMPOUND | VIP, NGLY1, NPPA | ABCB1 4820/4885ITGB3 4884/4885ITGA2B 4877/4885 |
| US-20130053348-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | MYLK, MYH2, MYH10 | ABCB1 1608/4885ITGB3 538/4885ITGA2B 657/4885 |
| US-20130281360-A1 | BROAD SPECTRUM ANTIBIOTIC ARYLOMYCIN ANALOGS | SPAST, NPEPPS, SPATS2L | ABCB1 949/4885ITGB3 4726/4885ITGA2B 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.